
TENX
Healthcare · Biotechnology · $73.8M market cap
$1.62+0.01 (+0.6%)Nov 13, 4:13 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +5.2% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | -0.35 | -0.31 | +11.4% |
| Jul 31, 2026 | Before the open | -0.38 | -0.35 | +7.9% |
| May 12, 2026 | Before the open | -0.40 | -0.35 | +12.5% |
| Mar 10, 2026 | Time not confirmed | -0.41 | -0.38 | +8.4% |
| Nov 12, 2025 | After the close | -1.12 | -0.40 | +64.3% |
| Aug 13, 2025 | After the close | -0.45 | -0.27 | +40.0% |
| May 14, 2025 | After the close | -0.41 | -0.28 | +31.7% |
| Mar 26, 2025 | Before the open | -0.42 | -0.18 | +57.6% |
| Nov 13, 2024 | Before the open | -1.37 | -0.19 | +86.1% |
| Aug 13, 2024 | After the close | -2.25 | -1.83 | +18.7% |
| May 14, 2024 | Before the open | -3.06 | -3.12 | -2.0% |
| Mar 28, 2024 | Before the open | -8.14 | -12.98 | -59.5% |
| Nov 13, 2023 | After the close | -7.20 |
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine…
| -6.40 |
| +11.1% |
| Aug 14, 2023 | After the close | -5.60 | -4.00 | +28.6% |
| May 15, 2023 | After the close | -29.60 | -12.00 | +59.5% |
| Mar 31, 2023 | Before the open | -2.28 | -1.73 | +24.1% |
| Nov 10, 2022 | After the close | -176.00 | -176.00 | 0.0% |
| Aug 11, 2022 | After the close | -144.00 | -176.00 | -22.2% |
| May 16, 2022 | After the close | -144.00 | -176.00 | -22.2% |
| Mar 31, 2022 | Before the open | -3.20 | -0.80 | +75.0% |
| Nov 15, 2021 | After the close | -208.00 | -240.00 | -15.4% |
| Aug 17, 2021 | Before the open | -256.00 | -160.00 | +37.5% |
| May 17, 2021 | After the close | -4.20 | -32.80 | -681.0% |
| Mar 31, 2021 | After the close | -288.00 | -960.00 | -233.3% |
| Nov 16, 2020 | After the close | -256.00 | -288.00 | -12.5% |
| Aug 14, 2020 | After the close | -320.00 | -368.00 | -15.0% |
| May 15, 2020 | After the close | -304.00 | -608.00 | -100.0% |
| Mar 30, 2020 | After the close | -12.10 | -8.20 | +32.2% |
| Nov 14, 2019 | After the close | -496.00 | -528.00 | -6.5% |
| Aug 14, 2019 | After the close | -576.00 | -448.00 | +22.2% |
| May 15, 2019 | After the close | -544.00 | -528.00 | +2.9% |
| Mar 31, 2019 | After the close | -6.20 | -0.91 | +85.3% |
| Nov 14, 2018 | After the close | -2336.00 | -1680.00 | +28.1% |
| Aug 14, 2018 | After the close | -1600.00 | -2064.00 | -29.0% |
| May 15, 2018 | After the close | -1712.00 | -1328.00 | +22.4% |
| Mar 20, 2018 | Time not confirmed | -1.60 | -0.94 | +40.9% |